title: [Acute lymphoblastic leukemia in children: history of drug therapy management].
abstract: The last forty years have witnessed major improvements in the survival of pediatric cancer patients with an evolution of acute tymphoblastic leukemia as an untreatable disease to acute lymphoblastic leukemia with a survival rate of more than 90%. This has become possible due to improvements in the various modalities of cancer therapy and supportive care. The aim of this commentary is to give an overview of the history of pharmacological treatment for children with acute Lymphoblastic leukemia.
authors.affiliation: Hopitâl Universitaire de Gand, Belgique.
authors.forename: T
authors.initials: T
authors.lastname: Bauters
authors.forename: Y
authors.initials: Y
authors.lastname: Benoit
mesh_terms: D002648:Child; D002675:Child, Preschool; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007223:Infant; D054539:Medication Therapy Management / Q000266:history / Q000639:trends*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000266:history / Q000628:therapy*; D015996:Survival Rate